KR102528145B1 - Method to produce bio-mineral beverage which is helpful for Diabetes - Google Patents
Method to produce bio-mineral beverage which is helpful for Diabetes Download PDFInfo
- Publication number
- KR102528145B1 KR102528145B1 KR1020220064338A KR20220064338A KR102528145B1 KR 102528145 B1 KR102528145 B1 KR 102528145B1 KR 1020220064338 A KR1020220064338 A KR 1020220064338A KR 20220064338 A KR20220064338 A KR 20220064338A KR 102528145 B1 KR102528145 B1 KR 102528145B1
- Authority
- KR
- South Korea
- Prior art keywords
- mineral
- solution
- water
- diabetes
- purified water
- Prior art date
Links
- 229910052500 inorganic mineral Inorganic materials 0.000 title claims abstract description 65
- 239000011707 mineral Substances 0.000 title claims abstract description 65
- 206010012601 diabetes mellitus Diseases 0.000 title claims abstract description 30
- 238000000034 method Methods 0.000 title claims abstract description 8
- 235000013361 beverage Nutrition 0.000 title 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims abstract description 50
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 38
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 claims abstract description 20
- 235000017647 Brassica oleracea var italica Nutrition 0.000 claims abstract description 20
- 240000003259 Brassica oleracea var. botrytis Species 0.000 claims abstract description 20
- VTIIJXUACCWYHX-UHFFFAOYSA-L disodium;carboxylatooxy carbonate Chemical compound [Na+].[Na+].[O-]C(=O)OOC([O-])=O VTIIJXUACCWYHX-UHFFFAOYSA-L 0.000 claims abstract description 14
- 230000035622 drinking Effects 0.000 claims abstract description 14
- 229940045872 sodium percarbonate Drugs 0.000 claims abstract description 14
- 239000000843 powder Substances 0.000 claims abstract description 11
- 238000004519 manufacturing process Methods 0.000 claims abstract description 6
- 238000002156 mixing Methods 0.000 claims abstract description 6
- 239000000243 solution Substances 0.000 claims description 35
- 239000008213 purified water Substances 0.000 claims description 20
- 238000003756 stirring Methods 0.000 claims description 7
- 238000001035 drying Methods 0.000 claims description 5
- 230000008569 process Effects 0.000 claims description 4
- 239000000126 substance Substances 0.000 claims description 4
- 238000001914 filtration Methods 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 239000002244 precipitate Substances 0.000 claims description 3
- 238000001223 reverse osmosis Methods 0.000 claims description 3
- 239000011550 stock solution Substances 0.000 claims description 3
- 238000011049 filling Methods 0.000 claims description 2
- 239000011874 heated mixture Substances 0.000 claims description 2
- 238000000605 extraction Methods 0.000 abstract description 6
- 229940091250 magnesium supplement Drugs 0.000 description 14
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 13
- 239000011777 magnesium Substances 0.000 description 13
- 229910052749 magnesium Inorganic materials 0.000 description 13
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 12
- 229910052720 vanadium Inorganic materials 0.000 description 12
- LEONUFNNVUYDNQ-UHFFFAOYSA-N vanadium atom Chemical compound [V] LEONUFNNVUYDNQ-UHFFFAOYSA-N 0.000 description 12
- 239000011701 zinc Substances 0.000 description 12
- 229910052725 zinc Inorganic materials 0.000 description 12
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 11
- 229910052804 chromium Inorganic materials 0.000 description 10
- 239000011651 chromium Substances 0.000 description 10
- 239000008280 blood Substances 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 7
- 238000004821 distillation Methods 0.000 description 6
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 6
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 239000001301 oxygen Substances 0.000 description 5
- 229910052760 oxygen Inorganic materials 0.000 description 5
- 206010022489 Insulin Resistance Diseases 0.000 description 4
- 239000003054 catalyst Substances 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 235000012054 meals Nutrition 0.000 description 4
- 238000005292 vacuum distillation Methods 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 102000004877 Insulin Human genes 0.000 description 3
- 108090001061 Insulin Proteins 0.000 description 3
- 108010007622 LDL Lipoproteins Proteins 0.000 description 3
- 102000007330 LDL Lipoproteins Human genes 0.000 description 3
- 208000002720 Malnutrition Diseases 0.000 description 3
- 206010061291 Mineral deficiency Diseases 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 229940125396 insulin Drugs 0.000 description 3
- 230000001071 malnutrition Effects 0.000 description 3
- 235000000824 malnutrition Nutrition 0.000 description 3
- 208000015380 nutritional deficiency disease Diseases 0.000 description 3
- 150000007524 organic acids Chemical class 0.000 description 3
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 208000008425 Protein deficiency Diseases 0.000 description 1
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- -1 anti-inflammatory Substances 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000036765 blood level Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 208000016097 disease of metabolism Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- GPRLSGONYQIRFK-UHFFFAOYSA-N hydron Chemical compound [H+] GPRLSGONYQIRFK-UHFFFAOYSA-N 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000002608 insulinlike Effects 0.000 description 1
- 108010022197 lipoprotein cholesterol Proteins 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 239000011435 rock Substances 0.000 description 1
- 235000019614 sour taste Nutrition 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 229910052723 transition metal Inorganic materials 0.000 description 1
- 150000003624 transition metals Chemical class 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 229940091251 zinc supplement Drugs 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01G—HORTICULTURE; CULTIVATION OF VEGETABLES, FLOWERS, RICE, FRUIT, VINES, HOPS OR SEAWEED; FORESTRY; WATERING
- A01G31/00—Soilless cultivation, e.g. hydroponics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/68—Treatment of water, waste water, or sewage by addition of specified substances, e.g. trace elements, for ameliorating potable water
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/328—Foods, ingredients or supplements having a functional effect on health having effect on glycaemic control and diabetes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/02—Acid
- A23V2250/032—Citric acid
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/15—Inorganic Compounds
- A23V2250/156—Mineral combination
- A23V2250/1638—Undefined mineral extract
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/24—Heat, thermal treatment
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Inorganic Chemistry (AREA)
- Diabetes (AREA)
- Mycology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Botany (AREA)
- Organic Chemistry (AREA)
- Environmental Sciences (AREA)
- Hematology (AREA)
- General Chemical & Material Sciences (AREA)
- Medical Informatics (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Alternative & Traditional Medicine (AREA)
- Hydrology & Water Resources (AREA)
- Environmental & Geological Engineering (AREA)
- Water Supply & Treatment (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
본 발명은 당뇨에 도움이 되는 바이오 미네랄수 제조 방법에 관한 것으로 더욱 상세하게는 당뇨환자에 결핍되기 쉬운 미네랄을 생체에 흡수되기 쉬운 액상으로 만들어 수경 재배에 투여하고, 수경 재배된 브로콜리를 바이오 미네랄 음용액으로 추출하여 마시므로 실제 당뇨 치료에 도움이 될 수 있는 바이오 미네랄수를 제공하는 것이다.The present invention relates to a method for producing bio-mineral water that is helpful for diabetes, and more particularly, by making minerals that are easily deficient in diabetic patients into a liquid form that is easily absorbed by the body and administering them to hydroponic cultivation, and hydroponically grown broccoli is used as a bio-mineral drink Since it is extracted and drunk as a solution, it provides bio-mineral water that can actually help treat diabetes.
현대인은 대부분 만성적인 미네랄 부족에 의한 영양실조의 상태에 있다고 할 수 있다. 과거의 영양실조가 단백질 부족에 의해서 나타났다면 현재의 영양실조는 미네랄 부족에 의해 초래된다고 볼 수 있다. 현대인의 건강에 미네랄의 중요성은 아무리 강조해도 지나치지 않다고 할 수 있다.Most modern people are in a state of malnutrition due to chronic mineral deficiency. If malnutrition in the past was caused by protein deficiency, current malnutrition is caused by mineral deficiency. The importance of minerals to the health of modern people cannot be overemphasized.
당뇨병은 인슐린 부족 혹은 인슐린 저항성에 의한 대사질환이라고 할 수 있다. 당뇨환자는 고농도의 혈당에 의해서 탄수화물 지방 단백질의 대사의 이상이 초래되는 것이 알려져 있다. Diabetes is a metabolic disease caused by insulin deficiency or insulin resistance. It is known that a high concentration of blood sugar in a diabetic patient causes an abnormality in the metabolism of carbohydrates, fats, and proteins.
최근 당뇨병이 미네랄 부족과 연관된다는 것도 보고되고 있으며, 당뇨환자에게 결핍되기 쉬운 미네랄을 제공하는 것은 가장 치유하기 어려운 만성질환인 당뇨병을 극복하기 위한 새로운 접근 방법이 될 수 있을 것이다. Recently, it has been reported that diabetes is associated with mineral deficiency, and providing minerals that are easily deficient to diabetic patients can be a new approach to overcome diabetes, which is the most difficult chronic disease to cure.
현대 과학이 밝힌 당뇨병과 관련 있는 미네랄은 다음과 같다.Minerals linked to diabetes by modern science are:
1. 마그네슘: 1. Magnesium:
최근 마그네슘 농도가 높은 식단이 당뇨의 치료에 도움이 된다는 보고가 있었고, 2형 당뇨병은 마그네슘의 혈중 농도가 낮은 것으로 나타났다. 그리고 마그네슘과 인슐린 저항성과도 관계가 보고되었다. 실제로 마그네슘 보충제의 섭취가 당뇨환자에게 도움이 된다는 것도 보고된 바 있다. Recently, there has been a report that a diet high in magnesium is helpful in treating diabetes, and type 2 diabetes has been shown to have low blood levels of magnesium. A relationship has also been reported between magnesium and insulin resistance. In fact, it has been reported that taking magnesium supplements is helpful for diabetic patients.
2. 아연:2. Zinc:
아연은 당뇨환자에게 포도당 농도 조절기능에 도움을 주는 것이 알려졌다. 실제 아연보충제를 사용하는 것이 인슐린 저항성을 갖는 사람에게 2형 당뇨병으로 발전하는 것을 막아주는 것이 보고되었다. 그 외에도 아연은 총 콜레스테롤 그리고 LDL(저밀도 지방단백질)과 중성지방의 농도를 줄여주는 것이 보고되었다. Zinc is known to be helpful in regulating glucose concentration in diabetic patients. In fact, it has been reported that using zinc supplements prevents the development of type 2 diabetes in people with insulin resistance. In addition, zinc has been reported to reduce total cholesterol and the concentration of LDL (low-density lipoprotein) and triglycerides.
마그네슘과 아연은 대사의 많은 기전에 작용하는 효소들에 직접적인 영향을 주기 때문에 마그네슘과 아연을 보충하는 것은 단지 당뇨뿐 아니라 전반적 인체 건강에 도움이 될 수 있다.Because magnesium and zinc directly affect enzymes that act on many mechanisms of metabolism, supplementing with magnesium and zinc can be beneficial not just for diabetes, but for overall human health.
3. 크롬과 바나듐:3. Chromium and Vanadium:
전이금소인 크롬과 바나듐의 경우 1형과 2형 당뇨의 증상을 개선하는데 도움이 되는 것으로 알려졌다.The transition metals chromium and vanadium are known to help improve symptoms of type 1 and type 2 diabetes.
크롬은 당뇨환자에게 그 필요성이 오랫동안 알려졌으나 당뇨와 바나듐의 연관성은 최근에 알려졌고 주목받고 있다. Chromium has long been known to be necessary for diabetic patients, but the relationship between diabetes and vanadium has recently been known and attracting attention.
크롬은 인슐린 민감성을 증가시키는 반면에 바나듐의 경우 인슐린과 같은 유사한 작용(insulin mimetic)을 하는 것으로 알려졌다. 높은 농도의 바나듐은 2형 당뇨환자는 인슐린 사용의 효율성을 증가시켜 주며 혈당과 콜레스테롤 그리고 LDL을 낮춰주는 것이 보고되었다. Chromium increases insulin sensitivity, whereas vanadium is known to have an insulin-like action (insulin mimetic). High concentrations of vanadium have been reported to increase the efficiency of insulin use in patients with type 2 diabetes and to lower blood glucose, cholesterol and LDL.
현재 당뇨환자에게 도움이 되는 것으로 알려진 미네랄인 마그네슘, 아연, 크롬, 바나듐은 염 형태의 불용성 보충제로 공급되며 인체 흡수율이 제한적이다. Currently, minerals such as magnesium, zinc, chromium, and vanadium, which are known to be helpful for diabetic patients, are supplied as insoluble supplements in the form of salts, and the absorption rate in the human body is limited.
본 발명은 염의 형태로 제공하는 미네랄의 인체 흡수율을 증가시키기 위해서 인체 친화적인 유기산과 쉽게 구할 수 있는 과탄산소다를 산소촉매로 이용하여 미네랄을 고농도로 액상화한 후, 브로콜리의 수경 재배에 투여하여 당뇨에 도움이 되는 바이오 미네랄수를 얻는데 그 목적이 있다.In order to increase the absorption rate of minerals provided in the form of salts by the human body, the present invention liquefies minerals at high concentration by using human-friendly organic acids and easily available sodium percarbonate as oxygen catalysts, and then administers them to hydroponic cultivation of broccoli to treat diabetes. The purpose is to obtain bio-mineral water that is helpful for
상기와 같은 목적을 달성하기 위하여 본 발명은 20ℓ용기에 역삼투압 정수기를 통과해서 이물질과 미네랄이 제거된 정제수 10ℓ를 채우고 구연산 2kg를 넣는 단계(S10); 상기 구연산이 삽입된 정제수를 80℃로 가열하면서 교반하고, 정제수에 미네랄분말 100g을 투여하는 단계(S20); 상기 미네랄분말을 투여한 후 80℃로 유지하면서 과탄산소다 200g을 1시간 동안 여러 번에 걸쳐 투여하고 교반하는 과탄산소다 투여 단계(S30); 최종 과탄산소다를 투여한 후 1시간 동안 80℃를 유지하면서 교반하는 최종 혼합 단계(S40); 상기 가열된 혼합물을 필터로 여과하여 침전물을 제거하는 과정을 통해 미네랄 용액을 추출하는 단계(S50)에 있어서,
상기 미네랄 용액 10000ppm을 정제수와 혼합하여 20ppm으로 희석한 다음에 25℃에서 브로콜리 씨앗을 20ppm 미네랄 용액에 15분간 침지하고 건조하여 심은 다음에 하루 4회씩 미네랄 용액을 분사하면서 7일간 수경 재배하는 단계(S60);
상기 7일간 수경 재배한 브로콜리는 80~120℃에서 2시간 건조한 후 물을 20%(w/w) 첨가하고 100℃에서 3psi의 감압 상태에서 바이오 미네랄 음용액을 추출하는 단계(S70)를 포함한다.In order to achieve the above object, the present invention includes the step of filling a 20-liter container with 10 liters of purified water from which foreign substances and minerals are removed through a reverse osmosis water purifier and adding 2 kg of citric acid (S10); stirring while heating the purified water into which the citric acid has been inserted at 80° C., and administering 100 g of mineral powder to the purified water (S20); Sodium percarbonate administration step of administering and stirring 200 g of sodium percarbonate several times for 1 hour while maintaining the temperature at 80° C. after administering the mineral powder (S30); A final mixing step (S40) of stirring while maintaining 80 ° C. for 1 hour after the final administration of sodium percarbonate; In the step (S50) of extracting the mineral solution through the process of filtering the heated mixture with a filter to remove the precipitate,
10000 ppm of the mineral solution was mixed with purified water and diluted to 20 ppm, then the broccoli seeds were immersed in the 20 ppm mineral solution at 25 ° C. for 15 minutes, dried and planted, and then sprayed with the mineral solution 4 times a day. Hydroponic cultivation for 7 days (S60 );
After drying the hydroponically grown broccoli for 7 days at 80-120 ° C. for 2 hours, adding 20% (w / w) water and extracting the bio-mineral drinking solution at 100 ° C. under reduced pressure of 3 psi (S70). .
상기와 같은 본 발명은 다음과 같은 효과가 있다.The present invention as described above has the following effects.
첫 번째는 구연산과 산소촉매를 이용하여 마그네슘, 아연, 크롬, 바나듐 등 당뇨에 도움이 되는 미네랄을 고농도 액상으로 만든 미네랄 용액을 브로콜리 수경 재배에 사용하여 설포라폰을 포함하는 브로콜리 추출물인 바이오 미네랄 음용액을 추출하는 효과가 있다. The first is a bio-mineral sound, which is a broccoli extract containing sulforaphone, by using a mineral solution made of magnesium, zinc, chromium, and vanadium, which are helpful for diabetes, in a high-concentration liquid state using citric acid and an oxygen catalyst for broccoli hydroponic cultivation. It has the effect of extracting the solution.
두 번째는 고농도의 바이오 미네랄이 함유되어 있는 브로콜리를 감압 증류방식으로 액상 추출한 바이오 미네랄 음용액을 정제수에 희석하여 당뇨환자들이 음용한 결과 혈당완화 등에 도움이 되는 효과가 있다.Second, a bio-mineral drinking solution obtained by liquid extraction of broccoli containing high-concentration bio-minerals by distillation under reduced pressure is diluted with purified water.
도 1은 본 발명에 따른 미네랄수 제조방법의 순서도 1 is a flowchart of a method for producing mineral water according to the present invention
이하에서 본 발명의 바람직한 실시를 위한 구체적인 내용을 첨부된 도면에 의하여 상세히 설명하면 다음과 같다.Hereinafter, specific details for preferred implementations of the present invention will be described in detail with reference to the accompanying drawings.
본 발명인 당뇨에 도움이 되는 바이오 미네랄수 제조방법은 구연산 투입 단계, 미네랄 분말 투여 단계, 과탄산소다 투여 단계, 최종 혼합 단계, 미네랄 용액 추출 단계, 수경 재배 단계, 바이오 미네랄 음용액 추출 단계를 포함한다.The method for producing bio-mineral water helpful for diabetes according to the present invention includes the steps of adding citric acid, administering mineral powder, administering sodium percarbonate, final mixing, extracting mineral solution, hydroponic cultivation, and extracting bio-mineral drinking solution. .
상기 구연산 투입 단계(S10)는, In the step of adding citric acid (S10),
20ℓ용기에 역삼투압 정수기를 통과해서 이물질과 미네랄이 제거된 정제수 10ℓ를 채우고, 용기 내부에 구연산 2kg를 넣는다.Fill a 20ℓ container with 10ℓ of purified water from which foreign substances and minerals have been removed through a reverse osmosis water purifier, and put 2kg of citric acid inside the container.
상기 구연산은 산의 일종으로 산화를 막는 천연방부제의 기능 및 신맛을 가지고 있으며, 항산화, 항염 작용과 미네랄 성분들의 흡수율을 높여주는 기능을 한다. 또한, 구연산은 기본적으로 산성물질이지만 소화과정을 거쳐 알칼리로 전환되어 작용하기 때문에 산성화된 몸을 중화시키는 효능이 있다. The citric acid is a kind of acid and has a function of a natural preservative that prevents oxidation and has a sour taste, and functions to increase the absorption rate of antioxidant, anti-inflammatory, and mineral components. In addition, citric acid is basically an acidic substance, but it has the effect of neutralizing the acidified body because it is converted to alkali through the digestion process.
상기 구연산(유기산)은 물에 녹지 않는 미네랄 성분을 용해키는 능력이 탁월하며, 추가 투여된 과탄산소다는 산소촉매로 작용하여 과산화수소를 발생하며 구연산의 용해작용을 증진시킨다. The citric acid (organic acid) has an excellent ability to dissolve mineral components that are insoluble in water, and the additionally administered sodium percarbonate acts as an oxygen catalyst to generate hydrogen peroxide and enhances the dissolving action of citric acid.
상기 미네랄 분말 투여 단계(S20)는,In the mineral powder administration step (S20),
상기 구연산이 삽입된 정제수를 80℃로 가열하면서 교반하고, 정제수에 미네랄분말 100g을 투여한다.The purified water into which the citric acid has been inserted is stirred while heating to 80° C., and 100 g of mineral powder is administered to the purified water.
상기 미네랄 분말은 가열된 정제수 속에 투입된 구연산과 서로 섞이게 되고, 구연산은 미네랄의 용해를 촉진한다.The mineral powder is mixed with citric acid introduced into the heated purified water, and the citric acid promotes the dissolution of minerals.
상기 미네랄 분말은 마그네슘, 아연, 바나듐, 크롬 중 어느 하나를 사용한다.The mineral powder uses any one of magnesium, zinc, vanadium, and chromium.
상기 과탄산소다 투여 단계(S30)는,In the step of administering sodium percarbonate (S30),
상기 미립의 미네랄 분말이 녹아있는 정제수를 80℃를 유지하면서 가열하면서 가열된 정제수 속에 산화제인 과탄산소다 200g을 1시간 동안에 여러 번에 걸쳐 투여하면서 교반한다.Purified water in which the fine mineral powder is dissolved is heated while maintaining 80° C., and 200 g of sodium percarbonate, an oxidizing agent, is added to the heated purified water several times for 1 hour while stirring.
상기 최종 혼합 단계(S40)는,In the final mixing step (S40),
상기 용기 내부에 최종 과탄산소다를 투여한 후 1시간 동안 80℃를 유지하면서 교반한다. 상기 과탄산소다는 정제수에 녹으면서 물과 산소로 분해하면서 촉매 반응으로 산화한다.After the final sodium percarbonate is administered into the container, the mixture is stirred while maintaining 80° C. for 1 hour. The sodium percarbonate is oxidized by a catalytic reaction while being dissolved in purified water and decomposed into water and oxygen.
상기 미네랄 용액 추출 단계(S50)는,In the mineral solution extraction step (S50),
상기 용기 내부에서 가열된 혼합물을 필터로 여과하여 침전물을 제거하는 과정을 통하여 미네랄 용액을 추출한다. 상기 미네랄 용액은 PH(수소이온 지수)는 4~5 정도이며, 원하는 농도로 희석하여 사용할 수 있다.A mineral solution is extracted through a process of filtering the mixture heated inside the vessel with a filter to remove precipitates. The mineral solution has a PH (hydrogen ion index) of about 4 to 5, and may be diluted to a desired concentration.
상기 미네랄 용액은 고농도 액상 당뇨용 미네랄 용액으로 당뇨에 도움이 되는 것으로 알려진 브로콜리를 수경 재배하는데 사용한다.The mineral solution is a high-concentration liquid mineral solution for diabetes and is used for hydroponic cultivation of broccoli known to be helpful for diabetes.
상기 수경 재배 단계(S60)는. The hydroponic cultivation step (S60).
10000ppm의 미네랄 용액은 정제수와 혼합하여 20ppm으로 희석한 다음에 25℃에서 브로콜리 씨앗을 20ppm 미네랄 용액에 15분간 침지하고 건조한다.The 10000 ppm mineral solution was diluted to 20 ppm by mixing with purified water, and then the broccoli seeds were immersed in the 20 ppm mineral solution at 25 ° C. for 15 minutes and dried.
상기 건조된 씨앗을 재배통에 심은 다음에 하루 4회씩 미네랄 용액을 분사하면서 7일간 수경으로 브로콜리를 재배한다.After planting the dried seeds in a cultivation tube, broccoli is cultivated hydroponically for 7 days while spraying a mineral solution four times a day.
상기 미네랄 용액은 마그네슘, 아연, 바나듐, 크롬 용액 중 어느 하나를 사용한다.As the mineral solution, any one of magnesium, zinc, vanadium, and chromium solutions is used.
상기 바이오 미네랄 음용액 추출 단계(S70)는,The bio-mineral drinking solution extraction step (S70),
상기 7일간 수경 재배한 브로콜리는 80~120℃에서 2시간 건조한 후 물을 20%(w/w) 첨가하고 100℃에서 감압 증류(3psi)하여 당뇨환자가 음용할 수 있는 바이오 미네날 음용액을 추출한다.After drying the broccoli grown hydroponically for 7 days at 80-120 ° C. for 2 hours, 20% (w / w) of water was added and distilled under reduced pressure (3 psi) at 100 ° C. to extract a biomineral drinking solution that can be consumed by diabetic patients do.
설포라폰을 포함하는 브로콜리 추출물인 바이오 미네랄 음용액은 당뇨에 도움이 되는 것이 이미 알려져 있으며, 실제로 바이오 미네랄 음용액을 섭취한 사람들의 혈당이 떨어지는 것이 보고된 바 있다. It is already known that the bio-mineral drinking solution, which is a broccoli extract containing sulforaphone, is helpful for diabetes, and it has been reported that people who actually consume the bio-mineral drinking solution have a drop in blood sugar.
수용성 마그네슘, 아연, 크롬, 바나듐 존재 하에서 수경 재배된 브로콜리는 높은 농도의 마그네슘, 아연, 크롬, 바나듐의 바이오 미네랄을 포함하는 것을 확인하였다. It was confirmed that broccoli grown hydroponically in the presence of water-soluble magnesium, zinc, chromium, and vanadium contained high concentrations of magnesium, zinc, chromium, and vanadium biominerals.
상기 감압 증류는 대기압보다 낮은 압력하에서의 증류로 진공 증류라고도 한다. 감압하 증류함으로써 상압 증류보다 낮은 온도에서 증류할 수 있다. The vacuum distillation is distillation under a pressure lower than atmospheric pressure and is also referred to as vacuum distillation. By distillation under reduced pressure, distillation can be performed at a lower temperature than atmospheric distillation.
상기 감압 증류 방식으로 추출된 수경 재배 브로콜리 용액의 미네랄 농도를 측정한 데이터는 표 1과 같다.Table 1 shows the data obtained by measuring the mineral concentration of the hydroponically grown broccoli solution extracted by the vacuum distillation method.
상기 수경 재배한 브로콜리를 80-120℃에서 2시간 건조한 후 물을 20%(w/w) 첨가하고 100℃에서 24시간 감압 증류하여 추출한 원액에 정제수를 약 33배 첨가하여 원액의 농도 대비 3% 농도의 용액으로 만들어서 당뇨환자들에게 아침과 저녁에 각 500ml씩 하루 1리터를 섭취하도록 한 후 가정용 혈당측정기로 한 달간 공복혈당과 식후 2시간 후 혈당을 측정한 결과 아래 표 2과 같이 당뇨환자들에서 혈당강화 효과가 관찰되었다. After drying the hydroponically grown broccoli at 80-120 ° C for 2 hours, 20% (w / w) of water was added, and about 33 times of purified water was added to the stock solution extracted by distillation under reduced pressure at 100 ° C for 24 hours to obtain a concentration of 3% compared to the concentration of the stock solution After making it into a concentrated solution and having diabetic patients take 1 liter a day, 500 ml each in the morning and evening, fasting blood sugar and blood sugar 2 hours after eating were measured with a home glucose meter for one month. As shown in Table 2 below, diabetic patients A hypoglycemic effect was observed.
공복(식후2시간)0 days
Fasting (2 hours after meal)
공복(식후2시간)10 days
Fasting (2 hours after meal)
공복(식후2시간)20 days
Fasting (2 hours after meal)
공복(식후2시간)30 days
Fasting (2 hours after meal)
상기와 같은 본 발명은 고농도의 바이오 미네랄이 함유되어 있는 브로콜리를 감압 증류방식으로 액상 추출한 바이오 미네랄 음용액을 정제수에 희석하여 당뇨환자들이 음용한 결과 혈당완화 등에 도움이 되는 것을 확인할 수 있다.In the present invention as described above, it can be confirmed that the biomineral drinking solution obtained by liquid extraction of broccoli containing high concentration of biominerals by vacuum distillation is diluted with purified water, and as a result of drinking by diabetic patients, it is helpful in relieving blood sugar.
Claims (3)
상기 미네랄 용액 10000ppm을 정제수와 혼합하여 20ppm으로 희석한 다음에 25℃에서 브로콜리 씨앗을 20ppm 미네랄 용액에 15분간 침지하고 건조하여 심은 다음에 하루 4회씩 미네랄 용액을 분사하면서 7일간 수경 재배하는 단계(S60);
상기 7일간 수경 재배한 브로콜리는 80~120℃에서 2시간 건조한 후 물을 20%(w/w) 첨가하고 100℃에서 3psi의 감압 상태에서 바이오 미네랄 음용액을 추출하는 단계(S70)를 포함하는 당뇨에 도움이 되는 바이오 미네랄수 제조방법. Filling a 20 ℓ container with 10 ℓ of purified water from which foreign substances and minerals are removed through a reverse osmosis water purifier and adding 2 kg of citric acid (S10); stirring while heating the purified water into which the citric acid has been inserted at 80° C., and administering 100 g of mineral powder to the purified water (S20); Sodium percarbonate administration step of administering and stirring 200 g of sodium percarbonate several times for 1 hour while maintaining the temperature at 80° C. after administering the mineral powder (S30); A final mixing step (S40) of stirring while maintaining 80 ° C. for 1 hour after the final administration of sodium percarbonate; In the step (S50) of extracting the mineral solution through the process of filtering the heated mixture with a filter to remove the precipitate,
10000 ppm of the mineral solution was mixed with purified water and diluted to 20 ppm, then the broccoli seeds were immersed in the 20 ppm mineral solution at 25 ° C. for 15 minutes, dried and planted, and then sprayed with the mineral solution 4 times a day. Hydroponic cultivation for 7 days (S60 );
After drying the hydroponically grown broccoli for 7 days at 80-120 ° C. for 2 hours, adding 20% (w / w) water and extracting a bio-mineral drinking solution under reduced pressure of 3 psi at 100 ° C. (S70) Manufacturing method of bio-mineral water that is helpful for diabetes.
상기 미네랄 음용액은 수경 재배한 브로콜리를 80-120℃에서 2시간 건조한 후 물을 20%(w/w) 첨가하고 100℃에서 24시간 감압 증류하여 추출한 원액에 정제수를 약 33배 첨가하여 원액의 농도 대비 3% 농도의 용액으로 만들었서 음용하는 것을 포함하는 당뇨에 도움이 되는 바이오 미네랄수 제조방법. According to claim 1,
The mineral drinking solution was obtained by drying broccoli grown hydroponically at 80-120 ° C for 2 hours, adding 20% (w / w) of water, distilling at 100 ° C for 24 hours under reduced pressure, and adding about 33 times purified water to the extracted stock solution. A method for producing bio-mineral water that is helpful for diabetes, including making a solution of 3% concentration compared to the concentration and drinking it.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020220064338A KR102528145B1 (en) | 2022-05-25 | 2022-05-25 | Method to produce bio-mineral beverage which is helpful for Diabetes |
PCT/KR2023/006871 WO2023229304A1 (en) | 2022-05-25 | 2023-05-19 | Method for producing therapeutically beneficial bio-mineral water for diabetes |
CN202310600698.XA CN117122610A (en) | 2022-05-25 | 2023-05-25 | Preparation method of biological mineral matter 'hall drainage' for facilitating diabetes |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020220064338A KR102528145B1 (en) | 2022-05-25 | 2022-05-25 | Method to produce bio-mineral beverage which is helpful for Diabetes |
Publications (1)
Publication Number | Publication Date |
---|---|
KR102528145B1 true KR102528145B1 (en) | 2023-05-03 |
Family
ID=86380245
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020220064338A KR102528145B1 (en) | 2022-05-25 | 2022-05-25 | Method to produce bio-mineral beverage which is helpful for Diabetes |
Country Status (3)
Country | Link |
---|---|
KR (1) | KR102528145B1 (en) |
CN (1) | CN117122610A (en) |
WO (1) | WO2023229304A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2023229304A1 (en) * | 2022-05-25 | 2023-11-30 | 미온바이오 주식회사 | Method for producing therapeutically beneficial bio-mineral water for diabetes |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20150136668A (en) * | 2014-05-27 | 2015-12-08 | 전주대학교 산학협력단 | Composition for antidiabetic or antiobesity activity comprising sprout extract as effective component |
KR20170072830A (en) * | 2015-12-16 | 2017-06-27 | 주식회사 아리바이오 | mineral having cure effects and use thereof |
KR20180021767A (en) * | 2018-02-21 | 2018-03-05 | 이정복 | Mineral nutrition composition for cultivating organic mineral sprout and cosmetic composition or functional food comprising thereof |
KR102316078B1 (en) | 2020-01-22 | 2021-10-25 | (주)킴스워터 | Liquefaction method of rock and insoluble mineral using organic acid and oxygen catalyst |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101239540B1 (en) * | 2010-12-24 | 2013-03-06 | 박노연 | Method of maunfacturing mineral water for plant growth promoting and method of using thereof |
KR101873931B1 (en) * | 2017-10-10 | 2018-08-03 | 김승기 | Manufacturing method for functional mineral water of ionized calcium using natural material |
KR102528145B1 (en) * | 2022-05-25 | 2023-05-03 | 미온바이오 주식회사 | Method to produce bio-mineral beverage which is helpful for Diabetes |
-
2022
- 2022-05-25 KR KR1020220064338A patent/KR102528145B1/en active IP Right Grant
-
2023
- 2023-05-19 WO PCT/KR2023/006871 patent/WO2023229304A1/en unknown
- 2023-05-25 CN CN202310600698.XA patent/CN117122610A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20150136668A (en) * | 2014-05-27 | 2015-12-08 | 전주대학교 산학협력단 | Composition for antidiabetic or antiobesity activity comprising sprout extract as effective component |
KR20170072830A (en) * | 2015-12-16 | 2017-06-27 | 주식회사 아리바이오 | mineral having cure effects and use thereof |
KR20180021767A (en) * | 2018-02-21 | 2018-03-05 | 이정복 | Mineral nutrition composition for cultivating organic mineral sprout and cosmetic composition or functional food comprising thereof |
KR102316078B1 (en) | 2020-01-22 | 2021-10-25 | (주)킴스워터 | Liquefaction method of rock and insoluble mineral using organic acid and oxygen catalyst |
Non-Patent Citations (1)
Title |
---|
네이버블로그('당하수 당하식 닥터삼한끼 먹고 코로나19 이겨내장 김고봉 중성지방 당하식 당뇨 위염 혈압 고지혈증 콜레스테롤 가이드', https://blog.naver.com/kim30843/222589134792, 2021. 12. 7.) 사본1부.* * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2023229304A1 (en) * | 2022-05-25 | 2023-11-30 | 미온바이오 주식회사 | Method for producing therapeutically beneficial bio-mineral water for diabetes |
Also Published As
Publication number | Publication date |
---|---|
WO2023229304A1 (en) | 2023-11-30 |
CN117122610A (en) | 2023-11-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI114010B (en) | A process for the preparation of pharmaceutical products for the treatment of tumor diseases | |
KR102528145B1 (en) | Method to produce bio-mineral beverage which is helpful for Diabetes | |
ES2294188T3 (en) | MEDICATIONS FOR THE TREATMENT OF DIABETES CONTAINING DEUTERIO. | |
US20050260277A1 (en) | Method and formula for anti-tumor and anti-matastatic effect | |
CN101947240A (en) | Mixed sugar electrolyte drug composite injection | |
CN104703486A (en) | Citrate-rich calcium-magnesium supplement and uses thereof | |
CN103385889B (en) | Carbohydrate and electrolyte mixed injection and preparation method thereof | |
CN101961347A (en) | Medicinal composition for treating cancer and use thereof | |
KR20090118175A (en) | The method of separating from either natural minerals or metal oxides, metals and producing the mineral water | |
WO2001015745A9 (en) | Method and formula for tumor remission and suppression of cancer | |
CN106236707A (en) | A kind of preparation method of carboxylic maltose ferrum | |
JP2013535415A (en) | Use of deuterium-reduced water for the treatment of insulin resistance | |
CN103239461A (en) | Vitamin B complex injection and preparation method thereof | |
DE3943424A1 (en) | Solns. for intravenous nutrition - contg. alpha-keto acids, for patients with kidney conditions, avoids nitrogen cpd. build-up | |
KR20090110423A (en) | Use of heme-iron polypeptide as iron supplement in beverage | |
CN108079035A (en) | A kind of hypoglycemic anti-inflammatory nutrient solution and preparation method thereof | |
US6518247B1 (en) | Method for producing an antitumoral agent and antitumoral agent thus obtained | |
CN108402470A (en) | A kind of nutrition fortifier and its beverage and preparation method of supplement zinc selenium rubidium | |
EP1675598B1 (en) | Nutrition trace element composition | |
CN107854485A (en) | The medical composition and its use of the various trace elements of injection | |
JP7036324B2 (en) | Anti-blood coagulation agent, blood coagulation improving device, blood coagulation improving method, vascular endothelial cell function improving method and metabolism improving method | |
KR20040064647A (en) | Method for production of solvent for high solution of calcium, calcium powder with high solubility thereof and calcium liquid thereof | |
CN107854486A (en) | The medical composition and its use of the various trace elements of injection | |
CN101953848B (en) | Medicament for treating cancer and application thereof | |
CN116239204A (en) | Drinking water containing lithium element and preparation method and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |